UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039715
Receipt number R000039872
Scientific Title Feasibility, safety, and efficacy of pediatric constraint-induced movement therapy for patients with upper extremity hemiparesis
Date of disclosure of the study information 2020/03/06
Last modified on 2020/03/05 18:21:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility, safety, and efficacy of pediatric constraint-induced movement therapy for patients with upper extremity hemiparesis

Acronym

Pediatric constraint-induced movement therapy

Scientific Title

Feasibility, safety, and efficacy of pediatric constraint-induced movement therapy for patients with upper extremity hemiparesis

Scientific Title:Acronym

Pediatric constraint-induced movement therapy

Region

Japan


Condition

Condition

Patients with upper extremity hemiparesis due to
cerebral palsy, stroke, brain tumor and traumatic brain injury.

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although recent studies showed that constraint-induced movement therapy (CIMT) is effective for pediatric patients with upper extremity hemiplegia, there are few studies in Japan. Therefore, there is a need to determine if the CIMT is effective in Japan. The purpose of this study is to evaluate the feasibility, safety, and effectiveness of CIMT for pediatric patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Outcome Measures
1) The feasibility of research protocol
2) Adverse events
3) Jebsen Taylor Test of Hand Function Test

Assessment timing
Outcome measures were assessed at baseline, after intervention, 1 month follow up, 6 months follow up and 12 months follow up.

Statistical assessment
Short-term effect: t test or Wilcoxon signed rank test
Long-term effect: ANOVA or Kruskal-Wallis or Dunnet Tukey-Kramer,or Bonferroni method

Key secondary outcomes

(1) Fugl-Meyer Assessment
(2) Pediatric Motor Activity Log-Revised

Assessment timing
Outcome measures were assessed at baseline, after intervention, 1 month follow up, 6 months follow up and 12 months follow up.

Statistical assessment
Short-term effect: t test or Wilcoxon signed rank test
Long-term effect: ANOVA or Kruskal-Wallis or Dunnet Tukey-Kramer,or Bonferroni method


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intervention Technique: CIMT

Training Dose: more than 30 hours

Training Period: 3 Months

CIMT components: 1) constraining the patient to use the more-impaired UE, 2) repetitive, task-oriented training of the more-impaired UE, 3) transfer package (translating the gains made in the laboratory into the patient's real-world environment).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

20 years-old >

Gender

Male and Female

Key inclusion criteria

Patient with cerebral palsy
1) Gross Motor Function Classification System: 1-3
2) Manual ability classification system: 1-4

Other patients
1) Possible to walk independently
2) Brunnstrom recovery stage: 3-6

Key exclusion criteria

1) Unable to understand simple order
2) Uncontrolled complications
3) Unable to obtain informed consent

Target sample size

22


Research contact person

Name of lead principal investigator

1st name Kazuhisa
Middle name
Last name Domen

Organization

Hyogo college of medicine

Division name

Department of rehabilitation medicine

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya, Hyogo, Japan

TEL

0798-45-6111

Email

umejiume@hyo-med.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Umeji

Organization

Hyogo college of medicine college hospital

Division name

Department of physical medicine and rehabilitation

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya, Hyogo, Japan

TEL

0798-45-6388

Homepage URL


Email

umejiume@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo college of medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo college of medicine

Address

1-1, Mukogawa-cho, Nishinomiya, Hyogo, Japan

Tel

0798-45-6111

Email

umejiume@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 02 Month 12 Day

Date of IRB

2019 Year 02 Month 12 Day

Anticipated trial start date

2019 Year 02 Month 12 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 05 Day

Last modified on

2020 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039872


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name